Nicolas Tricaud

Nicolas Tricaud is a co-founder and Chief Executive Officer at Nervosave Therapeutics, a role they have held since 2021. With over four years of experience in the therapeutic field, they also serve as a Principal Investigator at Inserm since 2011. Nicolas completed their PhD in Neurobiology and Neurosciences at Aix-Marseille Université and has held research positions at prestigious institutions including Memorial Sloan Kettering Cancer Center, ETH Zürich, and the University of Oxford. They are currently pursuing an HDR in Neuroscience at Université de Montpellier.